|
|
|
| A study on the effect of Cucurbitacin B on the inflammatory reaction of murine alveolar macrophages induced by lipopolysaccharide |
| ZHOU Kang, ZHANG Yong-wei, LU Xin-jian, MA Chun-fang
|
| Xinhua Hospital of Zhejiang Province,Hangzhou,Zhejiang,310005,China |
|
|
|
|
Abstract Objective To investigate the anti-inflammatory effect of Cucurbitacin B on the inflammatory reaction of murine alveolar macrophages induced by lipopolysaccharide and its molecular mechanism. Methods The alveolar macrophages were randomly divided into five groups: blank group, LPS group, different concentrations of Cucurbitacin B (1μM, 2.5μM, 5μM)+) +LPS groups. All group cells were pretreated with different concentrations for 2 h, and followed by 1μg/mL LPS. The protein level of TNF-α,IL-1β,IL-6 and PGE2 were detected by ELISA assay, and the NO was detected by Griess methods, and its upstream protein i-NOS,COX-2, Nrf2 and HO-1 were detected by Western-blot. Results The secretion of TNF-α,IL-1β,IL-6 and PGE2 in LPS group were increased significantly than blank groups, while Cucurbitacin B suppressed its protein level inadose-dependent manner. The nuclear erythroid related factor 2 and antioxidant gene were activated while Cucurbitacin B was added into alveolar macrophages in adose-dependent manner. Conclusion Cucurbitacin B can inhibit the extracellar secretion of inflammatory cytokines production, and its molecular mechanism could be due to the promoting Nrf2 translocation to the nucleus, activating the expression of HO-1 gene, reducing the expression of iNOS and COX-2, and thereby alleviating the inflammatory reaction.
|
|
Received: 04 January 2017
Revised: 13 April 2017
Published: 15 November 2017
|
|
|
|
|
|
[1] 张延亭,欧阳东云,何贤辉. 葫芦素B抗肿瘤作用及其机制研究进展[J]. 中国药理学与毒理学杂志,2012,26（1）：112-115.
[2] 张美侠,张洪亮,孙春艳,等. 葫芦素B在体内外对乳腺癌细胞的生长抑制作用[J]. 现代肿瘤医学,2009,17（1）：16-19.
[3] 刘亭彦,张美侠,邓意辉,等. 葫芦素B对喉癌细胞增殖和凋亡的影响及其机制研究[J]. 临床耳鼻咽喉头颈外科杂志,2008,22（9）：403-407.
[4] YANG T,LIU J,YANG M,et al. Cucurbitacin B exerts anti-cancer activities in human multiple myeloma cells in vitro and in vivo by modulating multiple cellular pathways[J]. Oncotarget,2017,8（4）：5800-5813.
[5] DONG L,WANG S,CHEN M,et al. The activation of macrophage and upregulation of CD40 costimulatory molecule in lipopolysaccharide-induced acute lung injury[J]. J Biomed Biotechnol,2008（2008）：852571.
[6] DE PAOLI F,STAELS B,CHINETTI-GBAGUIDI G. Macrophage phenotypes and their modulation in atherosclerosis[J]. Circ J,2014,78（8）：1775-1781.
[7] KIM H R,KIM K W,JUNG H G,et al. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis[J]. Arthritis Res Ther,2011,13（2）：R43.
[8] NISHIHIRA J,MITSUYAMA K. Overview of the role of macrophage migration inhibitory factor （MIF） in inflammatory bowel disease[J]. Curr Pharm Des,2009,15（18）：2104- 2109.
[9] JEYASEELAN S,CHU H W,YOUNG S K,et al. Transcriptional profiling of lipopolysaccharide-induced acute lung injury[J]. Infect Immun,2004,72（12）：7247-7256.
[10] LAM D,HARRIS D,QIN Z. Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation[J]. Mediators of Inflammation,2013（2013）：1-9.
[11] QIN X,QIU C,ZHAO L. Lysophosphatidylcholine perpetuates macrophage polarization toward classically activated phenotype in inflammation[J]. Cell Immunol,2014,289（1-2）：185- 190.
[12] BRUSCIA E M,BONFIELD T L. Cystic fibrosis lung immunity：the role of the macrophage[J]. J Innate Immun,2016,8（6）：550-563.
[13] LUCAS K,MAES M. Role of the Toll Like receptor （TLR） radical cycle in chronic inflammation：possible treatments targeting the TLR4 pathway[J]. Mol Neurobiol,2013,48（1）： 190-204.
[14] GUO C,YANG L,WAN C X,et al. Anti-neuroinflammatory effect of Sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK,JAK/STAT and Nrf2/HO-1 signaling pathways[J]. Phytomedicine,2016,23（13）： 1629-1637.
[15] ZHU J,WANG H,CHEN F,et al. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy[J]. Free Radic Biol Med,2016（99）： 544-556.
[16] SEO K,YANG J H,KIM S C,et al. The antioxidant effects of isorhamnetin contribute to inhibit COX-2 expression in response to inflammation：a potential role of HO-1[J]. Inflammation,2014,37（3）：712-722. |
|
|
|
